Muchler v. Penwarden

207 A.D.2d 977, 617 N.Y.S.2d 87, 1994 N.Y. App. Div. LEXIS 10165
Appellate Division of the Supreme Court of the State of New York·Decided September 30, 1994·Published·Cited by 1 cases

Opinion

—Order unanimously affirmed with costs. Memorandum: Supreme Court properly denied defendant’s motion to dismiss the second cause of action. The allegation that defendant failed to inform plaintiff of the risks associated with the use of the prescribed medications Thorazine and Sinemet could support plaintiff’s right to recover for medical malpractice based on a lack of informed consent (see, Public Health Law § 2805-d [2]; Marchione v State of New York, 194 AD2d 851; Dooley v Skodnek, 138 AD2d 102). (Appeal from Order of Supreme Court, Steuben County, Bradstreet, J.—Dismiss Cause of Action.) Present—Denman, P. J., Green, Balio, Doerr and Boehm, JJ.

Free access — add to your briefcase to read the full text and ask questions with AI

Muchler v. Penwarden, 207 A.D.2d 977, 617 N.Y.S.2d 87, 1994 N.Y. App. Div. LEXIS 10165 (N.Y. Ct. App. 1994).

207 A.D.2d 977 (Muchler v. Penwarden) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Kuperstein Ex Rel. Kuperstein v. Hoffman-Laroche, Inc.
457 F. Supp. 2d 467 (S.D. New York, 2006)